At baseline, plasma MnSOD activity was lower in TD patients than in non-TD patients and healthy controls, which is consistent with previous reports showing lower SOD in plasmas, red cell and CSF of TD patients [6, 14]. The gene discussed is SOD2; the disease is thanatophoric dysplasia.